Japan approves Alzheimer's blood test kit

By Agence France-Presse

Dec 23, 2022 12:14 am

TOKYO: Japan has approved a blood test kit to diagnose Alzheimer's disease, its manufacturer announced on Thursday, a rare advance in tackling a condition that affects tens of millions of people worldwide.

Sysmex Corp. said it was now working to get the kit, which measures the accumulation of a protein that is a marker for the disease, to market 'as soon as possible.'

This Oct. 7, 2003 file photo shows a closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening, researchers reported Tuesday, Nov. 29, 2022. AP PHOTO

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Zelenskyy says Trump is key to ending Russia-Ukraine conflict

Modi ends tour, secures nuke deals with US, France

Japan to release rice reserves as prices soar

Indonesia hands rhino poachers long sentences

Six dead in SKorean port city fire

Tropical cyclone hits Western Australia

Hamas to free 3 hostages this weekend